Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of assurance of sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 12, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Ongoing Historical recordClass II

Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 68788-9438-6); c) 90-count bottle (NDC 68788-9438-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8095-9

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9

by Preferred Pharmaceuticals, Inc.

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Carton NDC 0093-7487-56, Packet NDC 0093-7487-19

by Teva Pharmaceuticals USA Inc

Reason: Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-121-60.

by Direct Rx

Reason: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534.

by Direct Rx

Reason: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0240-30.

by Direct Rx

Reason: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.

by Preferred Pharmaceuticals, Inc.

Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bottle (NDC 68788-7595-9); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.

by Preferred Pharmaceuticals, Inc.

Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3

by Preferred Pharmaceuticals, Inc.

Reason: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count bottles (NDC 70518-0060-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701

by RemedyRePack Inc.

Reason: cGMP Deviations
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

by RemedyRePack Inc.

Reason: cGMP Deviations
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

by RemedyRePack Inc.

Reason: cGMP Deviations
Published: April 12, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00

by RemedyRePack Inc.

Reason: cGMP Deviations
Published: April 12, 2023
Distribution: Nationwide

View recall →

Data last updated: September 12, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.